|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.00 GBX | +4.35% |
|
+1.41% | +24.14% |
| 24/02 | Avacta hails new data supporting proprietary preCision platform | AN |
| 24/02 | Avacta Therapeutics Plans FAP-Exd's Clinical Trials After 'Favorable' Experimental Analysis | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.89Cr | -2.63Cr | -3.92Cr | -2.49Cr | -5.28Cr | |||||
Depreciation & Amortization - CF | 11.25L | 14.61L | 19.5L | 26.38L | 14.28L | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 4T | 8T | 2L | 10L | 16T | |||||
Depreciation & Amortization, Total | 11.29L | 14.69L | 21.22L | 36.09L | 14.44L | |||||
Amortization of Deferred Charges, Total - (CF) | 10.25L | 9L | 9L | 62T | - | |||||
(Gain) Loss From Sale Of Asset | 6T | 30T | 52T | -2T | 9T | |||||
Asset Writedown & Restructuring Costs | 17.41L | - | 52.25L | 5L | - | |||||
(Income) Loss On Equity Investments - (CF) | 2L | - | 11.52L | 8L | 7L | |||||
Stock-Based Compensation (CF) | 31.08L | 50.83L | 74.9L | 29.06L | 41.07L | |||||
Net Cash From Discontinued Operations | - | 50T | -3L | - | 13.39L | |||||
Other Operating Activities, Total | 3L | -5L | 22.61L | 13.77L | 2.13Cr | |||||
Change In Accounts Receivable | -8L | -15.99L | 22.25L | 8L | -2L | |||||
Change In Inventories | -91T | 13T | 52T | 2L | - | |||||
Change In Accounts Payable | 16.27L | 5L | 15.96L | -3L | 6L | |||||
Change in Unearned Revenues | - | - | - | 28T | - | |||||
Cash from Operations | -1.06Cr | -2.05Cr | -1.64Cr | -1.49Cr | -2.36Cr | |||||
Capital Expenditure | -12.79L | -11.62L | -6L | -11.24L | -3L | |||||
Sale of Property, Plant, and Equipment | - | - | 50T | 60T | - | |||||
Cash Acquisitions | - | - | -2.49Cr | -77.99L | - | |||||
Sale (Purchase) of Intangible assets | -4L | -2L | -36T | -96T | -16T | |||||
Investment in Marketable and Equity Securities, Total | -2.02Cr | 2Cr | - | - | - | |||||
Other Investing Activities, Total | - | - | 4L | -42T | -10.92L | |||||
Cash from Investing | -2.19Cr | 1.87Cr | -2.5Cr | -90.01L | -14.31L | |||||
Long-Term Debt Issued, Total | - | - | 5.22Cr | - | - | |||||
Total Debt Issued | - | - | 5.22Cr | - | - | |||||
Short Term Debt Repaid, Total | - | - | - | - | -25.5L | |||||
Long-Term Debt Repaid, Total | -3L | -3L | -8L | -16.96L | -9L | |||||
Total Debt Repaid | -3L | -3L | -8L | -16.96L | -34.63L | |||||
Issuance of Common Stock | 5.49Cr | 5L | 94.86L | 4L | 3.19Cr | |||||
Other Financing Activities, Total | -29.6L | - | -40.32L | - | -23.18L | |||||
Cash from Financing | 5.16Cr | 2L | 5.69Cr | -12.98L | 2.61Cr | |||||
Foreign Exchange Rate Adjustments | - | 4T | 2L | 17T | 84T | |||||
Miscellaneous Cash Flow Adjustments | - | -1L | - | - | - | |||||
Net Change in Cash | 1.91Cr | -17.03L | 1.56Cr | -2.52Cr | 11.51L | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 93T | 1L | 2L | 3L | 1L | |||||
Cash Income Tax Paid (Refund) | - | - | 2L | -66.33L | -11.7L | |||||
Levered Free Cash Flow | -74.38L | -1.48Cr | -86.28L | -1.77Cr | -3.14Cr | |||||
Unlevered Free Cash Flow | -73.79L | -1.47Cr | -69.4L | -81.78L | -2.52Cr | |||||
Change In Net Working Capital | -11.08L | 26.16L | 9L | -31.63L | 1.06Cr | |||||
Net Debt Issued / Repaid | -3L | -3L | 5.14Cr | -16.96L | -34.63L |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















